| abstract |
The present invention relates to a docosahexaenoic acid ester, including an alcohol selected from the group consisting of nicotinol, panthenol, inositol, isosorbide and isosorbide mononitrate, or one of the pharmaceutically acceptable salts, enantiomers, diastereoisomers or mixtures thereof, including racemic mixtures, for use thereof as a drug for the prophylactic and / or curative treatment of sickle cell disease. |